News

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...
A phase 2 trial evaluated peanut OIT in adults with peanut-allergic using real-world peanut products, employing a Simon’s minimax two-stage design with stop:go futility analysis. Participants ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...